CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion | +1,280 | $13.71 | $18K | 33,151 |
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion | +1,858 | $13.71 | $25K | 35,009 |
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion | +56,984 | $23.85 | $1.4M | 91,993 |
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion | +45,000 | $29.03 | $1.3M | 136,993 |
| 2020-06-22 | Howton David T EVP, General Counsel | Sale | −6,009 | $168.61 | $1.0M | 130,984 |
| 2020-06-22 | Howton David T EVP, General Counsel | Sale | −8,086 | $169.56 | $1.4M | 122,898 |
| 2020-06-22 | Howton David T EVP, General Counsel | Sale | −35,757 | $170.59 | $6.1M | 87,141 |
| 2020-06-22 | Howton David T EVP, General Counsel | Sale | −55,270 | $171.50 | $9.5M | 31,871 |
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −1,280 | 0 | ||
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −1,858 | 0 | ||
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −56,984 | 0 | ||
| 2020-06-22 | Howton David T EVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −45,000 | 7,708 | ||
| 2020-02-28 | Howton David T EVP, General Counsel | Grant or award | +6,700 | 31,871 | ||
| 2020-02-28 | Howton David T EVP, General Counsel | Grant or award · Stock option (right to buy) | +37,500 | 37,500 | ||
| 2019-12-13 | Howton David T EVP, General Counsel | Exercise or conversion | +18,579 | $13.90 | $258K | 43,750 |
| 2019-12-13 | Howton David T EVP, General Counsel | Exercise or conversion | +59,421 | $23.85 | $1.4M | 103,171 |
| 2019-12-13 | Howton David T EVP, General Counsel | Sale | −78,000 | $125.50 | $9.8M | 25,171 |
| 2019-12-13 | Howton David T EVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −18,579 | 0 | ||
| 2019-12-13 | Howton David T EVP, General Counsel | Exercise or conversion · Stock option (right to buy) | −59,421 | 56,984 | ||
| 2019-11-22 | Howton David T EVP, General Counsel | Exercise or conversion | +5,685 | $13.71 | $78K | 24,388 |
Page 1 of 4 · 74 trades